Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	4.85% 75.00	71.53	57.79	46.70	94.58
Operating Expenses	16.21% 142.27	169.80	119.91	111.76	100.95
Benefits Costs and Expenses	15.92% 143.36	170.51	120.67	114.49	103.21
Costs And Expenses	16.21% 142.27	169.80	119.91	111.76	100.95
Operating Income/Loss	31.54% -67.28	-98.27	-62.12	-65.06	-6.374
Income/Loss From Continuing Operations Before Tax	30.94% -68.36	-98.98	-62.88	-67.79	-8.638
Income Tax Expense/Benefit	100.00% -	-0.325	-0.678	-0.617	2.58
Income/Loss From Continuing Operations After Tax	30.71% -68.36	-98.65	-62.20	-67.17	-11.22
Net Income/Loss	30.71% -68.36	-98.65	-62.20	-67.17	-11.22
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7,284% 47.39	0.6418	47.12	43.67	43.52
Diluted Average Shares	7,284% 47.39	0.6418	47.12	43.67	43.52
Basic Earnings Per Share	32.39% -1.44	-2.13	-1.32	-1.54	-0.26
Diluted Earnings Per Share	32.39% -1.44	-2.13	-1.32	-1.54	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-